Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 2/20 | 0.35 |
| ▸ | GABBR1 | Q9UBS5 | 2/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 8/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | BPTF | Q12830 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21135778 | 0.83 | GABBR2 (0.38) | GABBR2GABBR1ALDH1A1TSHRGABRB1 | |
| SCHEMBL21135981 | 0.83 | ALDH1A1 (0.38) | EPHX2ALDH1A1TSHRHSD17B10 | |
| SCHEMBL21135972 | 0.80 | GABBR2 (0.39) | GABBR2GABBR1ALDH1A1TSHRGABRB1 | |
| SCHEMBL21135963 | 0.80 | GABBR2 (0.36) | GABBR2GABBR1EPHX2ALDH1A1GABRB1 | |
| SCHEMBL21135989 | 0.80 | ALDH1A1 (0.36) | EPHX2ALDH1A1TSHRHSD17B10 | |
| SCHEMBL21136386 | 0.79 | NPSR1 (0.38) | EPHX2ALDH1A1TSHRHSD17B10 | |
| SCHEMBL21135716 | 0.78 | ALDH1A1 (0.42) | EPHX2ALDH1A1TSHR | |
| SCHEMBL21135968 | 0.77 | EPHX1 (0.37) | GABBR2GABBR1EPHX2ALDH1A1GABRB1 | |
| SCHEMBL21135929 | 0.77 | EPHX2 (0.38) | EPHX2ALDH1A1 | |
| SCHEMBL21135772 | 0.77 | CA12 (0.40) | GABBR2GABBR1EPHX2ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190196326-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD OF MANUFACTURING ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190196326-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, AND METHOD OF MANUFACTURING ELECTRONIC DEVICE | RER1, ACTR5, RAD51 | GABBR2 1946/4885GABBR1 2031/4885EPHX2 252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.